Literature DB >> 26425386

Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

João M N Duarte1.   

Abstract

From epidemiological studies it is known that diabetes patients display increased risk of developing dementia. Moreover, cognitive impairment and Alzheimer's disease (AD) are also accompanied by impaired glucose homeostasis and insulin signalling. Although there is plenty of evidence for a connection between insulin-resistant diabetes and AD, definitive linking mechanisms remain elusive. Cerebrovascular complications of diabetes, alterations in glucose homeostasis and insulin signalling, as well as recurrent hypoglycaemia are the factors that most likely affect brain function and structure. While difficult to study in patients, the mechanisms by which diabetes leads to brain dysfunction have been investigated in experimental models that display phenotypes of the disease. The present article reviews the impact of diabetes and AD on brain structure and function, and discusses recent findings from translational studies in animal models that link insulin resistance to metabolic alterations that underlie brain dysfunction. Such modifications of brain metabolism are likely to occur at early stages of neurodegeneration and impact regional neurochemical profiles and constitute non-invasive biomarkers detectable by magnetic resonance spectroscopy (MRS).

Entities:  

Keywords:  Alzheimer’s disease; Diabetes; Insulin; Metabolism; Neurodegeneration

Year:  2015        PMID: 26425386      PMCID: PMC4567214          DOI: 10.14336/AD.2014.1104

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  196 in total

1.  Moderate hypoglycaemia obliterates working memory in humans with and without insulin treated diabetes.

Authors:  I J Deary; A J Sommerfield; V McAulay; B M Frier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

Review 2.  Astrocytic involvement in learning and memory consolidation.

Authors:  Marie E Gibbs; Dana Hutchinson; Leif Hertz
Journal:  Neurosci Biobehav Rev       Date:  2008-03-27       Impact factor: 8.989

3.  Pentamethylquercetin protects against diabetes-related cognitive deficits in diabetic Goto-Kakizaki rats.

Authors:  Xian-Hui Li; Xin Xin; Yan Wang; Jian-zhao Wu; Zhen-dong Jin; Li-na Ma; Chun-jie Nie; Xiao Xiao; Yan Hu; Man-wen Jin
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data.

Authors:  E J Austin; I J Deary
Journal:  Diabetes Care       Date:  1999-08       Impact factor: 19.112

5.  Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment.

Authors:  G J Biessels; A Kamal; I J Urban; B M Spruijt; D W Erkelens; W H Gispen
Journal:  Brain Res       Date:  1998-07-27       Impact factor: 3.252

6.  Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

Authors:  George J Francis; Jose A Martinez; Wei Q Liu; Kevin Xu; Amit Ayer; Jared Fine; Ursula I Tuor; Gordon Glazner; Leah R Hanson; William H Frey; Cory Toth
Journal:  Brain       Date:  2008-11-16       Impact factor: 13.501

7.  Decreased cognitive function in aging non-insulin-dependent diabetic patients.

Authors:  L C Perlmuter; M K Hakami; C Hodgson-Harrington; J Ginsberg; J Katz; D E Singer; D M Nathan
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

8.  Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes.

Authors:  I J Deary; J R Crawford; D A Hepburn; S J Langan; L M Blackmore; B M Frier
Journal:  Diabetes       Date:  1993-02       Impact factor: 9.461

9.  Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration.

Authors:  Raimund I Herzog; Owen Chan; Sunkyung Yu; James Dziura; Ewan C McNay; Robert S Sherwin
Journal:  Endocrinology       Date:  2008-01-10       Impact factor: 4.736

10.  Cognitive profiles of children with insulin-dependent diabetes.

Authors:  C S Holmes; L C Richman
Journal:  J Dev Behav Pediatr       Date:  1985-12       Impact factor: 2.225

View more
  26 in total

1.  Glycogen Supercompensation in the Rat Brain After Acute Hypoglycemia is Independent of Glucose Levels During Recovery.

Authors:  João M N Duarte; Florence D Morgenthaler; Rolf Gruetter
Journal:  Neurochem Res       Date:  2017-01-12       Impact factor: 3.996

Review 2.  Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.

Authors:  Sebastian Bertram; Klara Brixius; Christian Brinkmann
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

3.  Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes.

Authors:  Joana Reis Pedro; Liane I F Moura; Ângela Valério-Fernandes; Filipa I Baptista; Joana M Gaspar; Bárbara S Pinheiro; Cristina Lemos; Fernanda Neutzling Kaufmann; Carla Morgado; Carla S da Silva-Santos; Isaura Tavares; Samira G Ferreira; Eugénia Carvalho; António F Ambrósio; Rodrigo A Cunha; João M N Duarte; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2020-05-16       Impact factor: 4.077

4.  Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain.

Authors:  Liane I F Moura; Cristina Lemos; Catherine Ledent; Eugénia Carvalho; Attila Köfalvi
Journal:  Brain Res Bull       Date:  2019-02-02       Impact factor: 4.077

5.  Atorvastatin prevents the development of diabetic neuropathic nociception by possible involvement of nitrergic system.

Authors:  Reyhaneh Akbarian; Mohsen Chamanara; Amir Rashidian; Alireza Abdollahi; Shahram Ejtemaei Mehr; Ahmad Reza Dehpour
Journal:  J Appl Biomed       Date:  2021-02-09       Impact factor: 1.797

6.  Short-term high-fat feeding exacerbates degeneration in retinitis pigmentosa by promoting retinal oxidative stress and inflammation.

Authors:  Oksana Kutsyr; Agustina Noailles; Natalia Martínez-Gil; Lucía Maestre-Carballa; Manuel Martinez-Garcia; Victoria Maneu; Nicolás Cuenca; Pedro Lax
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

7.  Glucose and lactate as metabolic constraints on presynaptic transmission at an excitatory synapse.

Authors:  Sarah J Lucas; Christophe B Michel; Vincenzo Marra; Joshua L Smalley; Matthias H Hennig; Bruce P Graham; Ian D Forsythe
Journal:  J Physiol       Date:  2018-03-26       Impact factor: 5.182

8.  NMR-based metabolomics characterizes metabolic changes in different brain regions of streptozotocin-induced diabetic mice with cognitive decline.

Authors:  Tingting Zhang; Hong Zheng; Kai Fan; Nengzhi Xia; Jiance Li; Changwei Yang; Hongchang Gao; Yunjun Yang
Journal:  Metab Brain Dis       Date:  2020-07-08       Impact factor: 3.584

Review 9.  Resveratrol, Metabolic Dysregulation, and Alzheimer's Disease: Considerations for Neurogenerative Disease.

Authors:  Alex J T Yang; Ahmed Bagit; Rebecca E K MacPherson
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

10.  Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications.

Authors:  David André Barrière; Christophe Noll; Geneviève Roussy; Farah Lizotte; Anissa Kessai; Karyn Kirby; Karine Belleville; Nicolas Beaudet; Jean-Michel Longpré; André C Carpentier; Pedro Geraldes; Philippe Sarret
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.